BackgroundCheck.run
Search For

John V HeymachHouston, TX

John Heymach Phones & Addresses

Houston, TX   

11402 Island Manor St, Pearland, TX 77584    713-4368480   

Social networks

John V Heymach

Linkedin

Work

Company: The University of Texas M.D. Anderson Cancer Center Address: 1515 Holcombe Boulevard, Houston, TX 77030

Education

School / High School: Stanford Univ Sch Of Med 1994

Ranks

Certificate: American Board of Internal Medicine Sub-certificate in Oncology (Internal Medicine)
Get Report
Control this profile

Mentions for John V Heymach

Career records & work history

Medicine Doctors

John Heymach Photo 1

Dr. John V Heymach, Houston TX - MD (Doctor of Medicine)

Address:
1500 Holcombe Blvd Suite 432, Houston, TX 77030
1515 Holcombe Blvd Suite 432, Houston, TX 77030
713-7926161 (Phone) 713-7921220 (Fax)
1515 Holcombe Blvd, Houston, TX 77030
Hospitals:
1500 Holcombe Blvd Suite 432, Houston, TX 77030
1515 Holcombe Blvd Suite 432, Houston, TX 77030
1515 Holcombe Blvd, Houston, TX 77030
The University of Texas M.D. Anderson Cancer Center
1515 Holcombe Boulevard, Houston, TX 77030
Education:
Medical Schools
Stanford Univ Sch Of Med
Graduated: 1994

John V. Heymach

Specialties:
Hematology/Oncology
Work:
MD Anderson Cancer Center Multi Specialties
1515 Holcombe Blvd UNIT 207, Houston, TX 77030
713-5637100 (phone) 713-5637109 (fax)
Education:
Medical School
Stanford University School of Medicine
Graduated: 1998
Procedures:
Chemotherapy
Conditions:
Acute Bronchitis, Acute Sinusitis, Constipation, Diabetes Mellitus (DM), Emphysema, Lung Cancer, Malignant Neoplasm of Female Breast, Peripheral Nerve Disorders
Languages:
English
Description:
Dr. Heymach graduated from the Stanford University School of Medicine in 1998. He works in Houston, TX and specializes in Hematology/Oncology. Dr. Heymach is affiliated with Memorial Hermann Texas Medical Center and University Of Texas MD Anderson Cancer Center.
John Heymach Photo 2

John Victor Heymach, Houston TX

Specialties:
Internal Medicine
Medical Oncology
Hematology & Oncology
Work:
M.D. Anderson Cancer Center
1515 Holcombe Blvd, Houston, TX 77030
Education:
Stanford University (1998)
John Heymach Photo 3

John V Heymach, Houston TX

Specialties:
Oncologist
Address:
1515 Holcombe Blvd, Houston, TX 77030
Education:
Doctor of Medicine
Board certifications:
American Board of Internal Medicine Sub-certificate in Oncology (Internal Medicine)

John Heymach resumes & CV records

Resumes

John Heymach Photo 12

John Heymach

Publications & IP owners

Us Patents

Medical Imaging Methods And Apparatus For Diagnosis And Monitoring Of Diseases And Uses Therefor

US Patent:
2009000, Jan 1, 2009
Filed:
Dec 22, 2005
Appl. No.:
11/794072
Inventors:
Raul A. Brauner - Framingham MA, US
John Heymach - Pearland TX, US
International Classification:
A61B 5/107
US Classification:
600481
Abstract:
Methods are disclosed for analyzing representations of one or more in situ structures in the body of a subject (e.g., a human subject or other animal subject) to glean information about the health of the subject. Methods are disclosed for diagnosing, staging, grading, and monitoring diseases. Methods also are disclosed for targeting treatments and screening, validating therapies based on the analysis of in situ patters (e.g., individual structural features or distributions), and monitoring the effectiveness of therapies.

Blood Vessel Imaging And Uses Therefor

US Patent:
2009032, Dec 31, 2009
Filed:
Jan 30, 2009
Appl. No.:
12/363283
Inventors:
Raul A. Brauner - Framingham MA, US
John Heymach - Pearland TX, US
George Naumov - Bookline MA, US
Kongbin Kang - Providence RI, US
Assignee:
Bio Tree Systems, Inc. - Framingham MA
International Classification:
A61K 49/00
G01N 33/00
C12Q 1/00
A61P 43/00
US Classification:
800 3, 424 91, 435 4
Abstract:
Methods are disclosed for analyzing representations of one or more structures in the body of a subject (e.g., a human subject or other animal subject) to glean information about the health of the subject or to evaluate the subject's response to a therapy or other condition. Aspects of the invention relate to obtaining structural information from casts (e.g., vascular casts from animal models) and using the information as a reference for evaluating structures in the body of a subject. Methods are disclosed for diagnosing, staging, grading, and monitoring diseases. Methods also are disclosed for targeting treatments, monitoring the effectiveness of therapies, and/or screening or validating therapies based analyzing structures (e.g., vascular structures) in a subject and comparing them to reference structures observed in casts obtained from models (e.g., animal models) of related diseases or conditions.

Binned Micro-Vessel Density Methods And Apparatus

US Patent:
2010015, Jun 24, 2010
Filed:
Jun 28, 2007
Appl. No.:
12/308908
Inventors:
Benjamin Kimia - Providence RI, US
Raul A. Brauner - Framingham MA, US
John Heymach - Pearland TX, US
Jesse Funaro - Providence RI, US
Assignee:
Bio-Tree Systems, Inc. - Framingham MA
International Classification:
C12Q 1/02
US Classification:
435 29
Abstract:
In one aspect, a method of obtaining micro-vessel density (MVD) measurements from an image of biological vasculature containing a plurality of vessels is provided. The method comprises acts of analyzing a region of interest of the image for each of a plurality of bins, each of the plurality of bins associated with a predetermined range of vessel sizes, the act of analyzing the region of interest including determining which of the plurality of bins that portions of any vessel subject matter identified in the region of interest belong based on a size associated with the respective portions of the vessel subject matter, and associating each portion of the vessel subject matter with the corresponding one of the plurality of bins to which the portion belongs, and computing at least one measurement for each of the plurality of bins, the at least one measurement related to the MVD of the portions of vessel subject matter associated with the respective bin.

Compounds With Anti-Tumor Activity Against Cancer Cells Bearing Tyrosine Kinase Inhibitor Resistant Egfr Mutations

US Patent:
2022019, Jun 23, 2022
Filed:
Apr 16, 2020
Appl. No.:
17/604689
Inventors:
- Austin TX, US
Monique NILSSON - Houston TX, US
John V. HEYMACH - Houston TX, US
Assignee:
Board of Regents, The University of Texas System - Austin TX
International Classification:
A61K 31/506
A61K 31/517
A61K 31/519
A61K 31/4706
A61K 31/5377
A61K 31/496
A61K 31/55
A61P 35/00
Abstract:
The present disclosure provides methods of treating cancer in a patient determined to have osimertinib resistant EGFR mutations by administering a second-generation quinazolinamine derivative tyrosine kinase inhibitor.

Compounds With Anti-Tumor Activity Against Cancer Cells Bearing Her2 Exon 21 Insertions

US Patent:
2022017, Jun 9, 2022
Filed:
Mar 27, 2020
Appl. No.:
17/600017
Inventors:
- Austin TX, US
John V. HEYMACH - Houston TX, US
Assignee:
Board of Regents, The University of Texas System - Austin TX
International Classification:
A61K 31/517
A61P 35/00
C07K 14/705
C07K 14/71
C07K 14/82
C07K 16/32
C12N 9/12
Abstract:
The present disclosure provides methods of treating cancer in a patient determined to have an HER2 exon 21 mutation by administering a third-generation tyrosine kinase inhibitor, such as poziotinib.

Compounds Against Cancer Bearing Tyrosine Kinase Inhibitor Resistant Egfr Mutations

US Patent:
2022017, Jun 9, 2022
Filed:
Apr 16, 2020
Appl. No.:
17/604560
Inventors:
- Austin TX, US
Monique NILSSON - Houston TX, US
John V. HEYMACH - Houston TX, US
Assignee:
Board of Regents, The University of Texas System - Austin TX
International Classification:
A61K 31/517
A61K 45/06
A61P 35/02
A61P 35/04
Abstract:
The present disclosure provides methods of treating cancer in a patient determined to have osimertinib resistant EGFR mutations by administering a third-generation tyrosine kinase inhibitor, such as poziotinib.

Compounds With Anti-Tumor Activity Against Cancer Cells Bearing Her2 Exon 19 Mutations

US Patent:
2021036, Nov 25, 2021
Filed:
Mar 27, 2019
Appl. No.:
17/042012
Inventors:
- Austin TX, US
John V. HEYMACH - Houston TX, US
Assignee:
Board of Regents, The University of Texas System - Austin TX
International Classification:
A61K 31/517
A61K 45/06
C07K 14/71
A61P 35/00
C12Q 1/6886
Abstract:
The present disclosure provides methods of treating cancer in a patient determined to have a HER2 exon 19 mutation, such as a point mutation, by administering a third-generation tyrosine kinase inhibitor, such as poziotinib.

Molecular Subtyping Of Small Cell Lung Cancer To Predict Therapeutic Responses

US Patent:
2021006, Mar 4, 2021
Filed:
Sep 3, 2020
Appl. No.:
17/011519
Inventors:
- Austin TX, US
Lauren A. BYERS - Houston TX, US
John V. HEYMACH - Houston TX, US
Assignee:
Board of Regents, The University of Texas System - Austin TX
International Classification:
C12Q 1/6886
Abstract:
Provided herein are methods for determining a subtype of a small cell lung cancer in a patient based on the express status of ASCL1, NEUROD1, and POU2F3, which are expressed in a mutually exclusive fashion. The subtype of the cancer can be used to determine the sensitivity of the cancer to certain anti-cancer therapies. As such, also provided are methods of treating patients having small cell lung cancer based on the subtyping results.

Possible Relatives

John M Johnson  John Stamps  John R Stan  John Stanard  John R Stanaway  John R Stanbery  John L Stanbrough  John C Stanchak  John Stanchek  John C Stancil 

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.